JS Link

JS Link Intangible Assets

The Intangible Assets of JS Link (127120.KQ) as of Oct 26, 2026 is 183.76 M KRW. In the previous year, Intangible Assets was 194.08 M KRW — a change of -5.32% (lower).

Intangible Assets

183.76 MKRW

YoY

-5.32%

Last updated:

Intangible Assets of JS Link is 2024 183.76 M KRW. Intangible Assets of JS Link was 2023 194.08 M KRW. It decreases by -5.32% lower compared to the previous year.

The JS Link Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
2.90 B KRW
Jan 1, 2018
3.14 B KRW
Jan 1, 2019
1.86 B KRW
Jan 1, 2020
178.00 M KRW
Jan 1, 2021
166.79 M KRW
Jan 1, 2022
302.24 M KRW
Jan 1, 2023
194.08 M KRW
Jan 1, 2024
183.76 M KRW
The JS Link Intangible Assets history
YEARIntangible AssetsYoY
183.76 MKRW-5.32%
194.08 MKRW-35.79%
302.24 MKRW+81.21%
166.79 MKRW-6.30%
178.00 MKRW-90.45%
1.86 BKRW-40.62%
3.14 BKRW+8.17%
2.90 BKRW+53.06%
1.90 BKRW+25.73%
1.51 BKRW-4.07%
1.57 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JS Link Stock analysis

What does JS Link do? DNA Link, Inc. generates revenue through its genomic analysis services and products. The company offers genome biomarkers excavation products via the enhanced genome integration system (EGIS) brand, which includes high-quality data products, genomic analysis interpretation, and molecular diagnostic kit production technologies. Additionally, DNA Link provides personal genome analysis services under the deoxyribonucleic acid personalized services (DNAGPS) brand, targeting individuals seeking personalized genetic insights. The primary customers for EGIS are healthcare providers and research institutions requiring integrated genomic and clinical data solutions, while DNAGPS serves individual consumers interested in personalized health information. The enhanced genome integration system (EGIS) brand focuses on delivering comprehensive genomic analysis and clinical information integration, catering to the needs of medical professionals and research organizations. DNAGPS targets individual users who want detailed personal genome reports. Both product lines leverage DNA Link's expertise in genomic analysis and molecular diagnostics, ensuring high-quality data and interpretation services. The company's revenue streams are driven by the sale of these branded products to their respective target segments. DNA Link's business model centers around two core product lines: EGIS for professional and institutional clients and DNAGPS for individual consumers. EGIS products are sold to healthcare providers and research institutions that require advanced genomic data analysis and molecular diagnostic solutions. DNAGPS services are marketed directly to consumers seeking personalized genetic information. The company's revenue is derived from the licensing and sale of these branded genomic analysis services and products, with no mention of additional revenue sources in the business description. JS Link is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JS Link stock

Intangible Assets of JS Link is 183.76 M KRW in 2024.

Intangible Assets of JS Link changed from 194.08 M KRW to 183.76 M KRW, representing a -5.32% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets JS Link since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's JS Link historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JS Link

All Key Metrics — JS Link